Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Sodium Oxybate

    Virtual Booth

    Contact Supplier

    Sodium Oxybate

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    gamma Hydroxybutyrate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 230Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Avadel Pharma Completes Phase 3 REVITALYZ Trial Enrollment
    Avadel Pharma Completes Phase 3 REVITALYZ Trial Enrollment

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3207569/0/en/Avadel-Pharmaceuticals-Announces-Completion-of-Enrollment-in-Phase-3-REVITALYZ-Trial-in-Idiopathic-Hypersomnia.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    Tris Pharma's NDA For Low-Sodium Oxybate In Narcolepsy Accepted
    Tris Pharma's NDA For Low-Sodium Oxybate In Narcolepsy Accepted

    09 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251209571909/en/Tris-Pharma-Announces-FDA-Acceptance-of-NDA-for-Once-Nightly-Low-Sodium-Oxybate-Product-for-Narcolepsy-and-Idiopathic-Hypersomnia

    BUSINESSWIRE
    09 Dec 2025
    Share Share
    Ascent’s Generics Sodium Oxybate Receives Approval in US
    Ascent’s Generics Sodium Oxybate Receives Approval in US

    05 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210523

    FDA
    05 Nov 2025
    Share Share
    Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution
    Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution

    11 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/11/3148505/0/en/Amneal-Receives-U-S-FDA-Approval-of-Sodium-Oxybate-Oral-Solution.html

    GLOBENEWSWIRE
    11 Sep 2025
    Share Share
    Amneal`s Generics Sodium Oxybate Receives Approval in US
    Amneal`s Generics Sodium Oxybate Receives Approval in US

    10 Sep 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203631

    FDA
    10 Sep 2025
    Share Share
    Avadel Pharma to Present Lumryz Data at World Sleep 2025
    Avadel Pharma to Present Lumryz Data at World Sleep 2025

    05 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/05/3145233/0/en/Avadel-Pharmaceuticals-to-Present-New-Data-on-LUMRYZ-sodium-oxybate-for-Extended-Release-Oral-Suspension-at-World-Sleep-2025.html

    GLOBENEWSWIRE
    05 Sep 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.